Your browser doesn't support javascript.
loading
Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors.
Chiou, Wei-Chung; Hsu, Meng-Shiuan; Chen, Yun-Ti; Yang, Jinn-Moon; Tsay, Yeou-Guang; Huang, Hsiu-Chen; Huang, Cheng.
Afiliação
  • Chiou WC; Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Hsu MS; Departments of Infectious Disease, Far Eastern Memorial Hospital, Taipei, Taiwan.
  • Chen YT; Institute of Bioinformatics and Systems Biology, National Chiao Tung University, Hsinchu, Taiwan.
  • Yang JM; Institute of Bioinformatics and Systems Biology, National Chiao Tung University, Hsinchu, Taiwan.
  • Tsay YG; Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.
  • Huang HC; Center for Intelligent Drug Systems and Smart Bio-devices, National Chiao Tung University, Hsinchu, Taiwan.
  • Huang C; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan.
J Enzyme Inhib Med Chem ; 36(1): 147-153, 2021 Dec.
Article em En | MEDLINE | ID: mdl-33430659

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Inibidores de Cisteína Proteinase / Reposicionamento de Medicamentos / Proteases 3C de Coronavírus / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Inibidores de Cisteína Proteinase / Reposicionamento de Medicamentos / Proteases 3C de Coronavírus / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article